$AQST
Aquestive Therapeutics, Inc. Stock $aqst

$aqst Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000162828023037100 Filed on November 06, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$13.21M	$13.00M
YoY Change	23.63%	13.43%
Cost Of Revenue	$4.679M	$4.798M
YoY Change	-11.8%	3.74%
Gross Profit	$8.527M	$8.204M
YoY Change	58.58%	19.98%
Gross Profit Margin	64.57%	63.1%
Selling, General & Admin	$9.550M	$7.385M
YoY Change	-19.15%	-40.73%
% of Gross Profit	112.0%	90.02%
Research & Development	$2.888M	$3.196M
YoY Change	-32.49%	-1.11%
% of Gross Profit	33.87%	38.96%
Depreciation & Amortization	$467.0K	$218.0K
YoY Change	17.63%	-60.86%
% of Gross Profit	5.48%	2.66%
Operating Expenses	$12.44M	$10.58M
YoY Change	-22.7%	-32.57%
Operating Profit	-$3.911M	-$2.377M
YoY Change	-63.49%	-73.15%
Interest Expense	-$2.108M	$1.256M
YoY Change	28.62%	-23.83%
% of Operating Profit
Other Income/Expense, Net	-$962.0K
YoY Change
Pretax Income	-$8.010M	-$2.175M
YoY Change	-35.15%	-82.65%
Income Tax	$101.0K	-$140.0K
% Of Pretax Income
Net Earnings	-$8.111M	-$2.035M
YoY Change	-34.33%	-83.77%
Net Earnings / Revenue	-61.42%	-15.65%
Basic Earnings Per Share		-$0.03
Diluted Earnings Per Share	-$0.12	-$0.03
COMMON SHARES
Basic Shares Outstanding	66.77M shares	61.73B shares
Diluted Shares Outstanding		64.68M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$23.87M	$24.92M
YoY Change	-12.47%	33.63%
Cash & Equivalents	$23.87M	$24.92M
Short-Term Investments
Other Short-Term Assets	$1.854M	$1.910M
YoY Change	-13.0%	-3.34%
Inventory	$6.769M	$7.079M
Prepaid Expenses
Receivables	$8.471M	$8.550M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$40.97M	$42.46M
YoY Change	2.7%	11.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.179M	$4.551M
YoY Change	-47.11%	6.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.438M	$5.454M
YoY Change	-15.7%	-7.45%
Total Long-Term Assets	$16.45M	$16.99M
YoY Change	4.21%	23.5%
TOTAL ASSETS
Total Short-Term Assets	$40.97M	$42.46M
Total Long-Term Assets	$16.45M	$16.99M
Total Assets	$57.42M	$59.45M
YoY Change	3.13%	14.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.926M	$9.994M
YoY Change	-10.26%	-9.74%
Accrued Expenses	$6.497M	$5.468M
YoY Change	-22.41%	-29.29%
Deferred Revenue	$1.551M	$2.637M
YoY Change	2.51%	240.7%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$22.00K	$4.610M
YoY Change	-99.88%	-67.59%
Total Short-Term Liabilities	$18.31M	$24.06M
YoY Change	-53.86%	-34.2%
LONG-TERM LIABILITIES
Long-Term Debt	$27.51M	$34.56M
YoY Change	-17.76%	-10.64%
Other Long-Term Liabilities	$2.016M	$2.011M
YoY Change	-98.01%	-6.86%
Total Long-Term Liabilities	$2.016M	$2.011M
YoY Change	-98.5%	-6.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.31M	$24.06M
Total Long-Term Liabilities	$2.016M	$2.011M
Total Liabilities	$163.9M	$162.4M
YoY Change	-5.93%	1.7%
SHAREHOLDERS EQUITY
Retained Earnings	-$319.1M	-$311.0M
YoY Change	2.53%	4.05%
Common Stock	$69.00K	$67.00K
YoY Change	25.45%	24.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$106.5M	-$102.9M
YoY Change
Total Liabilities & Shareholders Equity	$57.42M	$59.45M
YoY Change	3.13%	14.66%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$8.111M	-$2.035M
YoY Change	-34.33%	-83.77%
Depreciation, Depletion And Amortization	$467.0K	$218.0K
YoY Change	17.63%	-60.86%
Cash From Operating Activities	-$4.942M	-$2.350M
YoY Change	-158.51%	-183.66%
INVESTING ACTIVITIES
Capital Expenditures	$16.00K	$150.0K
YoY Change	-38.46%	-108.74%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$16.00K	-$150.0K
YoY Change	-38.46%	-91.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.913M	4.980M
YoY Change	1818.14%	-3708.7%
NET CHANGE
Cash From Operating Activities	-4.942M	-2.350M
Cash From Investing Activities	-16.00K	-150.0K
Cash From Financing Activities	3.913M	4.980M
Net Change In Cash	-1.045M	2.480M
YoY Change	-112.12%	159.96%
FREE CASH FLOW
Cash From Operating Activities	-$4.942M	-$2.350M
Capital Expenditures	$16.00K	$150.0K
Free Cash Flow	-$4.958M	-$2.500M
YoY Change	-158.88%	-155.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001398733
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27273000	usd
CY2022Q4	aqst	Trade And Other Receivables Net TradeAndOtherReceivablesNet	4704000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	5780000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2131000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	39888000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4085000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5211000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1435000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6451000	usd
CY2022Q4	us-gaap	Assets Assets	57070000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9946000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7967000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	255000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1513000	usd
CY2023Q3	aqst	Transfer Of Financial Assets Accounted For As Sales Amount Derecognized Current TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent	985000	usd
CY2022Q4	aqst	Transfer Of Financial Assets Accounted For As Sales Amount Derecognized Current TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent	1147000	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	18700000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	39528000	usd
CY2023Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	34555000	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	33448000	usd
CY2023Q3	aqst	Transfer Of Financial Assets Accounted For As Sales Amount Derecognized Noncurrent TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent	63511000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5509000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	32732000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2011000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	162375000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	67000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	207972000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-310966000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-102927000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	59448000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	15379000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2377000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	1256000	usd
CY2023Q3	aqst	Interest Expense Sale Of Future Revenues InterestExpenseSaleOfFutureRevenues	56000	usd
CY2022Q3	aqst	Interest Expense Sale Of Future Revenues InterestExpenseSaleOfFutureRevenues	2039000	usd
	aqst	Interest Expense Sale Of Future Revenues InterestExpenseSaleOfFutureRevenues	163000	usd
	aqst	Interest Expense Sale Of Future Revenues InterestExpenseSaleOfFutureRevenues	5837000	usd
CY2023Q3	aqst	Interest And Other Income Net InterestAndOtherIncomeNet	1514000	usd
CY2022Q3	aqst	Interest And Other Income Net InterestAndOtherIncomeNet	5000	usd
	aqst	Interest And Other Income Net InterestAndOtherIncomeNet	16156000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46828218	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-118554000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	344000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-8000	usd
CY2023Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	1000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	8068000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-109235000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	31000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	631000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-3000	usd
CY2023Q2	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-5792000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-106651000	usd
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	66767283	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	66740765	shares
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13002000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3196000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7385000	usd
	aqst	Interest And Other Income Net InterestAndOtherIncomeNet	34000	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-353000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2175000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-42058000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	144000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2035000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-12536000	usd
	us-gaap	Net Income Loss NetIncomeLoss	241000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-42058000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2035000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12536000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	241000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-42058000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.90
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.90
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64678761	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53424922	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59252768	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46828218	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64678761	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53424922	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61513736	shares
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	774000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2035000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-102927000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-82134000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	913000	usd
CY2022Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	0	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-13220000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-93143000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	15000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2219000	usd
CY2022Q2	us-gaap	Stockholders Equity Other StockholdersEquityOther	0	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-16302000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-96357000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	535000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-3000	usd
CY2022Q3	us-gaap	Stockholders Equity Other StockholdersEquityOther	2000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-12536000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-107819000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-42058000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1990000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1749000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	174000	usd
	aqst	Interest Expense Sale Of Future Revenues Excluding Amortization InterestExpenseSaleOfFutureRevenuesExcludingAmortization	0	usd
	aqst	Interest Expense Sale Of Future Revenues Excluding Amortization InterestExpenseSaleOfFutureRevenuesExcludingAmortization	5683000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-60000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-1257000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2687000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2111000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2758000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2357000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	10509000	usd
	aqst	Increase Decrease In Finance Lease Loans Payable IncreaseDecreaseInFinanceLeaseLoansPayable	0	usd
	aqst	Increase Decrease In Finance Lease Loans Payable IncreaseDecreaseInFinanceLeaseLoansPayable	-675000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1438000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18235000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	979000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	998000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1500000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-979000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2498000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	5274000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	3017000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3805000	usd
	aqst	Proceeds From Issuance And Exercise Of Warrants ProceedsFromIssuanceAndExerciseOfWarrants	8342000	usd
	aqst	Proceeds From Issuance And Exercise Of Warrants ProceedsFromIssuanceAndExerciseOfWarrants	5874000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	31000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	15000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	12548000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	1027000	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	1350000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	61000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11358000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2356000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9375000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28024000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24917000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18649000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4828000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24917000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-310966000	usd
CY2023Q3	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	1744000	usd
CY2022Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	2139000	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	35369000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	32930000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13002000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11463000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37377000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36998000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13002000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11463000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37377000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36998000	usd
CY2023Q3	us-gaap	Accounts Receivable Gross AccountsReceivableGross	6846000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	3274000	usd
CY2023Q3	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	1744000	usd
CY2022Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	2139000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40000	usd
CY2023Q3	aqst	Accounts Receivable Allowances And Accruals Trade And Other Receivables Net AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet	0	usd
CY2022Q4	aqst	Accounts Receivable Allowances And Accruals Trade And Other Receivables Net AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet	669000	usd
CY2023Q3	aqst	Trade And Other Receivables Net TradeAndOtherReceivablesNet	8550000	usd
CY2022Q4	aqst	Trade And Other Receivables Net TradeAndOtherReceivablesNet	4704000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40000	usd
CY2022Q4	aqst	Accounts Receivable Allowances And Accruals AccountsReceivableAllowancesAndAccruals	669000	usd
	aqst	Accounts Receivable Allowances Provision Reversal Related To Sales AccountsReceivableAllowancesProvisionReversalRelatedToSales	0	usd
	aqst	Accounts Receivable Allowances Credits And Payments AccountsReceivableAllowancesCreditsAndPayments	87000	usd
	aqst	Accounts Receivable Allowances Reclassifications AccountsReceivableAllowancesReclassifications	582000	usd
CY2023Q3	aqst	Accounts Receivable Allowances And Accruals AccountsReceivableAllowancesAndAccruals	0	usd
	aqst	Accounts Receivable Allowances Provision Reversal Related To Sales AccountsReceivableAllowancesProvisionReversalRelatedToSales	0	usd
	aqst	Accounts Receivable Allowances Provision Reversal Related To Sales AccountsReceivableAllowancesProvisionReversalRelatedToSales	0	usd
CY2023Q3	aqst	Accounts Receivable Allowances And Accruals Accounts Payable And Accrued Expenses AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses	659000	usd
CY2022Q4	aqst	Accounts Receivable Allowances And Accruals AccountsReceivableAllowancesAndAccruals	669000	usd
CY2022Q4	aqst	Accounts Receivable Allowances And Accruals Accounts Payable And Accrued Expenses AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses	1012000	usd
CY2022Q2	aqst	Pro Rata Portion Of Target Bonus ProRataPortionOfTargetBonus	280000	usd
CY2022Q2	aqst	Cash Payment Representing90 Days Of Base Pay CashPaymentRepresenting90DaysOfBasePay	150000	usd
CY2022Q2	aqst	Days Of Base Pay DaysOfBasePay	P90D
CY2022Q2	us-gaap	Severance Costs1 SeveranceCosts1	263000	usd
CY2022Q2	aqst	Number Of Installments NumberOfInstallments	3	installment
CY2022Q2	aqst	Severance Period SeverancePeriod	P18M
CY2022Q2	aqst	Coverage Duration CoverageDuration	P18M
CY2022Q2	aqst	Consulting Fee ConsultingFee	10000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1308000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	338000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	424000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1267000	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	1902000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1899000	usd
CY2023Q3	aqst	Inventory Packing Material Gross InventoryPackingMaterialGross	3427000	usd
CY2022Q4	aqst	Inventory Packing Material Gross InventoryPackingMaterialGross	2914000	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1750000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	967000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	7079000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	5780000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	47263000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	46048000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	42712000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	41963000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4551000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4085000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	218000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	557000	usd
	us-gaap	Depreciation Depreciation	760000	usd
	us-gaap	Depreciation Depreciation	1926000	usd
CY2023Q3	aqst	Number Of Operating Leases NumberOfOperatingLeases	3	lease
CY2022Q3	us-gaap	Variable Lease Cost VariableLeaseCost	110000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	333000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	303000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1230000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1266000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1300000	usd
CY2023Q3	aqst	Lessee Operating Lease Liability To Be Paid Year Four And Thereafter LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter	6318000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10417000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4541000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	5876000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4367000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4367000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3050000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2932000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1317000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1435000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	39000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	39000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	117000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	64000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	39000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	156000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	9171000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	19487000	usd
CY2023Q3	aqst	Cumulative Royalty Receivable CumulativeRoyaltyReceivable	4000000	usd
CY2022Q4	aqst	Cumulative Royalty Receivable CumulativeRoyaltyReceivable	5000000	usd
CY2023Q3	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	1454000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	1451000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5454000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6451000	usd
CY2023Q3	aqst	Number Of Guaranteed Royalty Payments NumberOfGuaranteedRoyaltyPayments	8	royalty_payment
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6389000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	322000	usd
CY2023Q3	aqst	Accounts Receivable Allowances And Accruals Accounts Payable And Accrued Expenses AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses	659000	usd
CY2022Q4	aqst	Accounts Receivable Allowances And Accruals Accounts Payable And Accrued Expenses AccountsReceivableAllowancesAndAccrualsAccountsPayableAndAccruedExpenses	1012000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1601000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5468000	usd
CY2019Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2000000	shares
CY2019Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.001
CY2019Q3	aqst	Net Proceeds From Issuance Of Initial Notes Warrants And First Offer Rights NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights	66082000	usd
	aqst	Premiums Paid Early Retirement Of Debt PremiumsPaidEarlyRetirementOfDebt	2250000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	38975000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	10317000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	38975000	usd
	aqst	Class Of Warrant Or Right Warrants Exercised ClassOfWarrantOrRightWarrantsExercised	0	shares
	aqst	Class Of Warrant Or Right Warrants Exercised ClassOfWarrantOrRightWarrantsExercised	0	shares
CY2022Q4	aqst	Liabilities Sale Of Future Royalties LiabilitiesSaleOfFutureRoyalties	65259000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	163000	usd
	aqst	Interest Expense Sale Of Future Revenues Excluding Amortization InterestExpenseSaleOfFutureRevenuesExcludingAmortization	0	usd
CY2023Q3	aqst	Liabilities Sale Of Future Royalties Current LiabilitiesSaleOfFutureRoyaltiesCurrent	985000	usd
CY2023Q3	aqst	Liabilities Sale Of Future Royalties LiabilitiesSaleOfFutureRoyalties	64496000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2035000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-12536000	usd
	us-gaap	Net Income Loss NetIncomeLoss	241000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-42058000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64678761	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53424922	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59252768	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46828218	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1547751	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64678761	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53424922	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61513736	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46828218	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.90
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.90
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	774000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	535000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1766000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3669000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1766000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3669000	usd
	aqst	Inducement Equity Common Stock Options Outstanding Shares InducementEquityCommonStockOptionsOutstandingShares	150000	shares
	aqst	Inducement Equity Common Stock Options Granted Shares InducementEquityCommonStockOptionsGrantedShares	150000	shares
CY2022Q4	us-gaap	Share Price SharePrice	1.53
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.064
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.374
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-140000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	144000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2175000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	385000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-12536000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-42058000	usd
	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-23-037100-index-headers.html	Edgar Link	pending
0001628280-23-037100-index.html	Edgar Link	pending
0001628280-23-037100.txt	Edgar Link	pending
0001628280-23-037100-xbrl.zip	Edgar Link	pending
aqst-09302023ex311.htm	Edgar Link	pending
aqst-09302023ex312.htm	Edgar Link	pending
aqst-09302023ex321.htm	Edgar Link	pending
aqst-09302023ex322.htm	Edgar Link	pending
aqst-20230930.htm	Edgar Link	pending
aqst-20230930.xsd	Edgar Link	pending
aqst-20230930_lab.xml	Edgar Link	unprocessable
aqst-20230930_cal.xml	Edgar Link	unprocessable
aqst-20230930_def.xml	Edgar Link	unprocessable
aqst-20230930_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
aqst-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AQST
Aquestive Therapeutics, Inc. Stock $aqst

2023 Q4 Form 10-Q Financial Statement

#000162828023037100 Filed on November 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AQST Aquestive Therapeutics, Inc. Stock $aqst

2023 Q4 Form 10-Q Financial Statement

#000162828023037100 Filed on November 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AQST
Aquestive Therapeutics, Inc. Stock $aqst